Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside
J Zhejiang Univ Sci B. 2023 May 13;24(10):868-882.
doi: 10.1631/jzus.B2200589.
[Article in
English,
Chinese]
Affiliations
- 1 Department of Oral Pathology, Peking University School and Hospital of Stomatology / National Center of Stomatology / National Clinical Research Center for Oral Diseases / National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China.
- 2 Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing 100081, China.
- 3 Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China. litiejun22@vip.sina.com.
- 4 Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing 100081, China. litiejun22@vip.sina.com.
- 5 Department of Oral Pathology, Peking University School and Hospital of Stomatology / National Center of Stomatology / National Clinical Research Center for Oral Diseases / National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China. zhangheyu1983@sina.cn.
- 6 Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing 100081, China. zhangheyu1983@sina.cn.
Oral leukoplakia is a common precursor lesion of oral squamous cell carcinoma, which indicates a high potential of malignancy. The malignant transformation of oral leukoplakia seriously affects patient survival and quality of life; however, it is difficult to identify oral leukoplakia patients who will develop carcinoma because no biomarker exists to predict malignant transformation for effective clinical management. As a major problem in the field of head and neck pathologies, it is imperative to identify biomarkers of malignant transformation in oral leukoplakia. In this review, we discuss the potential biomarkers of malignant transformation reported in the literature and explore the translational probabilities from bench to bedside. Although no single biomarker has yet been applied in the clinical setting, profiling for genomic instability might be a promising adjunct.
口腔白斑是一种常见的口腔潜在恶性病变，可恶变为口腔鳞状细胞癌，恶性潜能较高。白斑癌变严重影响患者的生存和生活质量，但因缺乏有效的癌变预测生物标志物，难以对其癌变潜能进行识别。作为头颈病理领域的重要问题之一，白斑癌变生物标志物的筛选将有助于鳞癌的早期诊断。本文通过综述白斑癌变相关生物标志物的相关研究，探讨从基础科研到临床转化的前景。目前虽尚无生物标志物应用于临床，但基因组不稳定性可能是一种具有应用前景的辅助方法。.
口腔白斑是一种常见的口腔潜在恶性病变，可恶变为口腔鳞状细胞癌，恶性潜能较高。白斑癌变严重影响患者的生存和生活质量，但因缺乏有效的癌变预测生物标志物，难以对其癌变潜能进行识别。作为头颈病理领域的重要问题之一，白斑癌变生物标志物的筛选将有助于鳞癌的早期诊断。本文通过综述白斑癌变相关生物标志物的相关研究，探讨从基础科研到临床转化的前景。目前虽尚无生物标志物应用于临床，但基因组不稳定性可能是一种具有应用前景的辅助方法。
Keywords:
Biomarker; Malignant transformation; Oral leukoplakia; Oral squamous cell carcinoma; Prognosis.
MeSH terms
-
Biomarkers
-
Carcinoma, Squamous Cell*
-
Head and Neck Neoplasms*
-
Humans
-
Leukoplakia, Oral
-
Mouth Neoplasms*
-
Quality of Life